Skip to main content
. 2021 Aug 21;17:863–875. doi: 10.2147/TCRM.S320533

Table 2.

Comparison of Characteristics of Patients with and without Mortality in the Training Cohort

Variables Survival (n=420) Death (n=69) P-value
Demographic characteristics
Sex, n (%) 0.059
Female 98 (23) 24 (35)
Male 322 (77) 45 (65)
Age, y 64.0 (51.8, 73.0) 70.0 (61.0, 77.0) < 0.001
Smoking, n (%) 273 (65) 41 (59) 0.447
Weekend on admission, n (%) 108 (26) 14 (20) 0.415
Delay, n (%) 92 (22) 27 (39) 0.003
Vascular risk factors
Hypertension, n (%) 256 (61) 41 (59) 0.914
Diabetes mellitus, n (%) 83 (20) 15 (22) 0.827
Prior-Stroke, n (%) 26 (6) 4 (6) 1
CKD, n (%) 85 (20) 22 (32) 0.044
OHCA, n (%) 16 (4) 28 (41) < 0.001
GRACE, score 122.0 (102.0, 145.0) 178.0 (142.0, 213.0) < 0.001
Clinical data
HR, beats/min 79.0 (72.0, 90.0) 86.0 (76.0, 110.0) < 0.001
SBP, mmHg 128.0 (110.0, 142.0) 109.0 (89.0, 130.0) < 0.001
DBP, mmHg 80.00 (68.00, 92.00) 73.00 (58.00, 85.00) < 0.001
Shock_index 0.6 (0.5, 0.7) 0.8 (0.7, 1.1) < 0.001
Killip, n (%) < 0.001
 1 343 (82) 26 (38)
 2 47 (11) 7 (10)
 3 14 (3) 9 (13)
 4 16 (4) 27 (39)
Electrocardiographic data
Inferior_wall, n (%) 196 (47) 23 (33) 0.053
Anterior_wall, n (%) 205 (49) 41 (59) 0.133
Other, n (%) 13 (3) 4 (6) 0.28
Right_ventricular, n (%) 5 (1) 1 (1) 0.601
Laboratory examinations on admission
WBC, *109/L 11.2 (8.4, 13.5) 13.6 (10.0, 18.1) < 0.001
Neutrophil_count, *109/L 8.6 (6.2, 11.1) 11.3 (7.8, 15.1) < 0.001
NLR 6.3 (3.9, 9.8) 9.7 (5.9, 14.8) < 0.001
PLR 152.0 (107.8, 223.3) 155.6 (87.2, 278.2) 0.93
MLR 0.5 (0.3, 0.8) 0.8 (0.4, 1.1) 0.003
SIRI 4.2 (2.5, 7.4) 7.9 (4.1, 14.1) < 0.001
SII 1236.8 (778.3, 2094.1) 2009.1 (1074.2, 2940.4) 0.005
HB, g/L 138.00 (122.00, 153.00) 126.00 (115.00, 147.00) 0.018
RBC, *1012/L 4.52 (3.98, 4.98) 4.17 (3.74, 4.85) 0.027
PLT, *109/L 209.5 (167.5, 256.2) 197.0 (157.0, 254.0) 0.286
ALT, U/L 30.0 (22.0, 48.0) 50.0 (26.0, 129.0) < 0.001
AST, U/L 63.0 (35.0, 139.2) 178.0 (64.0, 399.0) < 0.001
GGT, U/L 41.0 (25.8, 69.2) 55.0 (25.0, 83.0) 0.403
BUN, mmol/L 6.4 (5.1, 8.2) 10.2 (7.7, 13.1) < 0.001
Creatinine, umol/L 96.0 (79.0, 116.0) 135.0 (100.0, 181.0) < 0.001
Uuric acid, umol/L 470.0 (436.0, 527.0) 515.0 (449.0, 601.0) 0.003
Cystatin C, mg/L 1.2 (0.9, 1.5) 1.6 (1.2, 2.2) < 0.001
CK, U/L 423.0 (166.5, 1297.8) 744.0 (303.0, 1639.0) 0.006
CKMB, U/L 45.0 (23.0, 118.5) 86.0 (39.0, 182.0) 0.002
LDH, U/L 343.5 (253.0, 523.8) 655.0 (381.0, 1057.0) < 0.001
α-HBDH, U/L 233.5 (166.0, 404.5) 451.0 (276.0, 739.0) < 0.001
CTnT, ng/L 747.1 (175.7, 2914.2) 2590.0 (1140.0, 5476.0) < 0.001
BNP, pg/mL 870.1 (212.3, 2878.5) 6279.0 (2061.0, 21,400.0) < 0.001
Glucose, mmol/L 6.6 (5.6, 8.4) 7.9 (6.3, 10.6) < 0.001
Myoglobin, ng/mL 332.5 (94.4, 893.2) 677.1 (191.0, 1908.0) < 0.001
Procedural features
LM, n (%) 6 (1) 0 (0) 1
LAD, n (%) 129 (31) 20 (29) 0.882
LCX, n (%) 47 (11) 6 (9) 0.683
RCA, n (%) 102 (24) 16 (23) 0.964
Intrahospital complications
Post-Ventricular fibrillation, n (%) 19 (5) 25 (36) < 0.001
Post-Cardiogenic shock, n (%) 16 (4) 35 (51) < 0.001
Other
Total hospital duration stay, d 7.0 (5.0, 10.0) 2.0 (1.0, 4.0) < 0.001

Notes: Values are expressed as medians with interquartile ranges for continuous data. Other values are presented as numbers and percentages. Shock index ratio of HR to SBP.

Abbreviations: SIRI, systemic inflammatory response index; SII, systemic inflammatory reaction index; PLR, ratio of platelets to lymphocytes; NLR, the ratio of neutrophils to lymphocytes; MLR, ratio of monocytes to lymphocytes; OHCA, out-of-hospital cardiac arrest; GRACE, Global Registry of Acute Coronary Events score; α-HBDH, α-Hydroxybutyrate dehydrogenase; BNP, B-type natriuretic peptides.